Drugs / Tumor Treatment Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06430502 | May 2024 → Jun 2027 expected | cancer | Wuxi People's Hospital | Recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tumor Treatment Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06430502 ↗ |
| Known as | TTV | “tumor treatment vaccine(TTV), which would be given deep subcutaneously in the arm or near the tumor” NCT06430502 ↗ |
| Modality | Vaccine | “TTV vaccine” NCT06430502 ↗ |
| Route | Subcutaneous | “given deep subcutaneously” NCT06430502 ↗ |